Moneycontrol
Get App
Last Updated : Jun 11, 2015 05:33 PM IST | Source: PTI

AstraZeneca launches diabetes drug, stock up 20%

The pharma company had received the approval of Drug Controller General of India in February.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

AstraZeneca Pharma on Thursday said it has launched diabetes drug 'Forxiga' in India.


"Forxiga helps remove excess glucose from the body. It offers a new treatment approach for patients by improving glycaemic control with added benefits of weight loss and blood pressure reduction," AstraZeneca said in a filing to BSE.


"Forxiga tablets are indicated as a once daily oral medication to improve glycaemic control in adult patients with Type 2 diabetes mellitus". AstraZeneca Pharma MD Sanjay Murdeshwar said the drug would offer an additional treatment option to over 63 million diabetes mellitus patients in India.

Close

"Forxiga represents a significant advancement in the treatment of Type 2 diabetes mellitus with global safety and efficacy data of four years," he said.


The pharma company had received the approval of Drug Controller General of India in February.

The drug is currently approved in 40 countries, it said. AstraZeneca surged 20 percent to Rs 1,147.70 in early trade on BSE on Thursday.



Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on Jun 11, 2015 03:09 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant